Thanks, I'm still doing my DD here and a phase 3 would not be required for these products. They just need to show bio-equivalence and proof that the tamper resistant process works.
Yes, this is certainly a key priority for FDA and that will help move things along.
I look forward to learning more about ELTP for the group. Please feel free to point me in the direction of key resources for DD.
Market Data 
Markets 
AI
